Unibest
← Back to patent-cliff list

Seladelpar lysine dihydrate

Tier C — Watch / trade

Seladelpar lysine dihydrate

Cymabay Therapeutics Inc
Originator
2024
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type

Targets:PPARδ

Brand:LIVDELZI

Indications (approved):Biliary cirrhosis, Sclerosing cholangitis

Regional status

US
Approved
2024-08-14
EU
Approved
2025-02-20
China
Filed / under review
2025-11-12
Japan
-

Synthetic routes & intermediates1 routes

Originator routes × 1Optimised (non-patent) × 0Process routes × 0

Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.

OriginatorRoute 1Steps 7 · Total yield /
SELALD-001402-45-9SELALD-00257044-25-4SELALD-003256372-58-4SELALD-004343322-82-7SELALD-005851528-81-9SELALD-006851528-83-1SELALD-007851528-79-5SELALD-00893917-68-1SELALD-00991427-62-2Seladelpar lysine dihydrate928821-40-3API · Seladelpar lysine dihydrate
CodeCAS No.Intermediate
SELALD-001402-45-94-(trifluoromethyl)phenol
SELALD-00257044-25-4(R)-oxiran-2-ylmethanol
SELALD-003256372-58-4Available(S)-2-((4-(trifluoromethyl)phenoxy)methyl)oxirane
SELALD-004343322-82-7ethyl 2-(4-mercapto-2-methylphenoxy)acetate
SELALD-005851528-81-9ethyl (R)-2-(4-((2-hydroxy-3-(4-(trifluoromethyl)phenoxy)propyl)thio)-2-methylphenoxy)acetate
SELALD-006851528-83-1ethyl (R)-2-(4-((2-ethoxy-3-(4-(trifluoromethyl)phenoxy)propyl)thio)-2-methylphenoxy)acetate
SELALD-007851528-79-5(R)-2-(4-((2-ethoxy-3-(4-(trifluoromethyl)phenoxy)propyl)thio)-2-methylphenoxy)acetic acid
SELALD-00893917-68-1ethyl 2-(o-tolyloxy)acetate
SELALD-00991427-62-2Availableethyl 2-(4-(chlorosulfonyl)-2-methylphenoxy)acetate
Seladelpar lysine dihydrate928821-40-3(R)-2-(4-((2-ethoxy-3-(4-(trifluoromethyl)phenoxy)propyl)thio)-2-methylphenoxy)acetic acid compound with (S)-2,6-diaminohexanoic acid (1:1)

Frequently asked questions

What are the approved indications of Seladelpar lysine dihydrate?

Approved indications include: Biliary cirrhosis, Sclerosing cholangitis.

When does the Seladelpar lysine dihydrate patent expire?

No public expiry year is available for Seladelpar lysine dihydrate yet; this page updates once verified.

How many synthesis routes are recorded for Seladelpar lysine dihydrate?

1 synthesis routes are recorded; the shortest is 7 steps with / total yield. Intermediates in each route carry codes and CAS numbers.

Where can I buy Seladelpar lysine dihydrate intermediates?

2 intermediate CAS of Seladelpar lysine dihydrate are available through the Unibest supply network — see the route tables on this page and request a quote per CAS.

How do I get a quote for Seladelpar lysine dihydrate intermediates?

Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.

Source: cross-verified data (structured fields only) · 2026-09-29